KR100520645B1 - Cosmetic composition having anti-lifting effector - Google Patents

Cosmetic composition having anti-lifting effector Download PDF

Info

Publication number
KR100520645B1
KR100520645B1 KR10-2003-0050958A KR20030050958A KR100520645B1 KR 100520645 B1 KR100520645 B1 KR 100520645B1 KR 20030050958 A KR20030050958 A KR 20030050958A KR 100520645 B1 KR100520645 B1 KR 100520645B1
Authority
KR
South Korea
Prior art keywords
skin
cosmetic composition
weight
improve
effect
Prior art date
Application number
KR10-2003-0050958A
Other languages
Korean (ko)
Other versions
KR20050011895A (en
Inventor
공우식
이기무
백지훈
Original Assignee
애경산업(주)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 애경산업(주) filed Critical 애경산업(주)
Priority to KR10-2003-0050958A priority Critical patent/KR100520645B1/en
Publication of KR20050011895A publication Critical patent/KR20050011895A/en
Application granted granted Critical
Publication of KR100520645B1 publication Critical patent/KR100520645B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645Proteins of vegetable origin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/817Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
    • A61K8/8182Copolymers of vinyl-pyrrolidones. Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)

Abstract

본 발명은 진피층 내의 탄력성분을 증진시켜 피부탄력을 개선하고 피부표면에 단백질 막을 형성하여 처진 피부를 당겨주어 피부처짐을 개선하는 화장료 조성물에 관한 것으로, 본 발명의 화장료 조성물은 통상의 화장료 조성물에 디카르복시 카노신 하이드로클로라이드(Decarboxy Carnosine 2HCl; Carcinine) 0.1 ~ 2 중량%, 지실에서 추출한 에센셜 오일 0.001 ~ 0.5 중량% 및 소맥 단백질과 폴리비닐피롤리돈(polyvinylpyrrolidone, PVP)의 중합체 0.01 ~ 5.0중량%를 함유하는 것을 특징으로 한다.The present invention relates to a cosmetic composition that improves the elasticity in the dermal layer to improve skin elasticity and form a protein film on the skin surface to pull sagging skin to improve skin sagging, and the cosmetic composition of the present invention is applied to a conventional cosmetic composition. 0.1 to 2% by weight of Decarboxy Carnosine 2HCl (Carcinine), 0.001 to 0.5% by weight of essential oils extracted from cellar, and 0.01 to 5.0% by weight of polymer of wheat protein and polyvinylpyrrolidone (PVP) It is characterized by containing.

상기와 같이 구성되는 본 발명에 따른 피부처짐 개선 화장료 조성물은 콜라겐 합성효과가 있는 디카르복시 카노신 하이드로클로라이드와 엘라스틴 분해억제 효과가 있는 지실의 에센셜 오일 및 수분보유 효과와 피부조임 효과가 있는 소맥 단백질과 폴리비닐피롤리돈(polyvinylpyrrolidone, PVP)의 중합체를 각종 화장료에 일정성분으로 함유하여 진피의 피부탄력을 향상시키고 처진피부를 개선하는 유용한 작용이 있는 화장료 조성물을 제공한다.Skin sag improvement cosmetic composition according to the present invention is configured as described above is essential oil and moisture retention effect and skin tightening effect of dicarboxy carnosine hydrochloride and elastin degradation inhibitory effect collagen synthesis and By providing a polymer of polyvinylpyrrolidone (PVP) as a certain component in various cosmetics to provide a cosmetic composition having a useful action to improve the skin elasticity of the dermis and improve sagging skin.

Description

피부처짐 개선 화장료 조성물{Cosmetic composition having anti-lifting effector}Cosmetic composition for improving sagging skin {Cosmetic composition having anti-lifting effector}

본 발명은 처진 피부를 당겨줌으로 피부처짐을 개선하는 화장료 조성물에 관한 것으로, 더욱 자세하게는 진피층 내의 탄력성분을 증진시켜 피부탄력을 개선하고 피부표면에 단백질 막을 형성하여 처진 피부를 당겨주어 피부처짐을 개선하는 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition that improves skin sagging by pulling sagging skin, and more particularly, improves elasticity of the dermal layer to improve skin elasticity and forms a protein film on the skin surface to draw sagging skin. It relates to a cosmetic composition to improve.

진피는 결체조직으로서 신경, 혈관, 표피에서 기원한 표피 부속기를 포함하고 있다. 진피의 결체조직은 교원섬유 및 탄력섬유, 특별한 형체가 없는 기질(ground substance)로 구성되며 이들은 모두 섬유모세포(fibroblast)에 의해 만들어 진다.The dermis is a connective tissue containing epidermal appendages originating from nerves, blood vessels, and epidermis. The connective tissue of the dermis is composed of collagen fibers, elastic fibers, and a ground substance with no particular shape, all of which are made by fibroblasts.

교원질 콜라겐은 진피의 주성분으로 피부의 건조 중량의 75%를 차지한다. 콜라겐 분자는 분자간에 끝과 끝이 연결되는 것이 아니라 분자 측면끼리 가교(cross-link)되는 특징을 가지고 있어서 아미노산 구조와 함께 교원질이 장력(tensile strength)을 가지도록 만든다.Collagen collagen is the main component of the dermis and accounts for 75% of the dry weight of the skin. Collagen molecules are characterized by cross-linking of molecules rather than end-to-molecules, making collagen with tensile strength along with the amino acid structure.

탄력섬유는 진피의 건조 중량의 3%를 차지하며 주기능은 가해진 힘에 의해 변형된 피부가 원래의 모습으로 돌아오도록 피부에 탄력성을 제공하는 것이다. 성숙한 탄력섬유는 무정형(amorphous)의 불용성 단백질인 엘라스틴(elastin)이 약 90%를 차지하며 나머지는 미세섬유 단백질로 구성되어 있다. 한편 엘라스틴은 엘라스타제에 의해 분해되고 이는 피부탄력을 감소시키는 원인이 된다.Elastic fibers make up 3% of the dry weight of the dermis and the main function is to provide elasticity to the skin so that the deformed skin returns to its original appearance by the applied force. Mature elastic fibers comprise about 90% of elastin, an amorphous insoluble protein, with the remainder composed of microfiber proteins. Elastin, on the other hand, is broken down by elastase, which reduces skin elasticity.

이러한 피부탄력 감소의 문제점을 해결하여 피부탄력을 유지하여 피부처짐을 방지하기 위한 기술로는 대한민국 출원특허 제2000-0014487호에 실리콘 중합체의 타이트닝 효과에 의해 주름을 경감시키는 기술을 개시하고 있고, 대한민국 특허출원 제1999-0030187호는 대두, 맥아, 소맥 단백질에 의한 엘라스틴 분해 억제 및 콜라겐 분해 억제로 피부탄력효과를 증대시키는 기술을 개시하고 있으며, 대한민국 특허출원 제2001-0043836호는 Tat 펩타이드가 접합된 레티놀 유도체로 피부 흡수력을 증진시켜 콜라겐 합성 증진 및 엘라스틴 분해를 억제하는 기술을 개시하고 있으며, 대한민국 특허출원 제2000-0013995호는 율피추출물을 이용하여 피부탄력을 증진시키는기술을 각각 개시하고 있다.As a technology for preventing skin sagging by maintaining skin elasticity by solving the problem of skin elasticity reduction, Korean Patent Application No. 2000-0014487 discloses a technique for reducing wrinkles by a tightening effect of a silicone polymer, and Korea Patent application No. 1999-0030187 discloses a technique for enhancing skin elasticity effect by inhibiting elastin degradation and collagen degradation by soybean, malt, and wheat proteins, and Korean Patent Application No. 2001-0043836 discloses a conjugated Tat peptide. Retinol derivatives enhance skin absorption and disclose collagen synthesis and suppress elastin degradation, and Korean Patent Application No. 2000-0013995 discloses a technique for enhancing skin elasticity using Yulpi extract.

본 발명은 피부처짐을 개선할 수 있는 화장료를 제공하기 위한 것으로, 본 발명자 등은 처진 피부를 당겨줌으로 피부처짐을 개선할 수 있는 물질에 대해 연구하여 본 발명을 완성하였다. The present invention is to provide a cosmetic that can improve the skin sagging, the present inventors have completed the present invention by studying a material that can improve the skin sagging by pulling sagging skin.

즉, 본 발명의 목적은 진피층 내의 탄력성분을 증진시켜 피부탄력을 개선하고 피부표면에 단백질 막을 형성하여 처진 피부를 당겨주어 피부처짐을 개선할 수 있는 화장료 조성물을 제공하기 위한 것이다.That is, an object of the present invention is to provide a cosmetic composition that can improve skin elasticity by improving the elasticity in the dermal layer and improve the skin sagging by forming a protein film on the skin surface to pull sagging skin.

상기한 본 발명의 목적은 상기한 바와 같이 탄력섬유인 엘라스틴의 분해 억제 효과와 콜라겐 합성 증진 효과 등으로 피부탄력을 향상시킬 뿐 만 아니라 피부표면에 고분자 단백질 막을 형성시켜 수분보유 및 조임효과를 주어 피부의 처짐현상을 개선하는데 유효한 효과가 있는 물질을 통상의 화장료 조성물과 일정비율로 조합함에 의해 얻어지는 화장료 조성물을 제공함으로 달성되었다.The object of the present invention as described above is not only to improve the skin elasticity by inhibiting the degradation of the elastic fiber elastin and the collagen synthesis enhancement effect, but also to form a polymer protein membrane on the skin surface to give moisture and tightening effect to the skin It was achieved by providing a cosmetic composition obtained by combining a substance having an effective effect in improving the deflection phenomenon of the conventional cosmetic composition with a certain ratio.

상기한 목적을 달성하기 위한 본 발명의 피부처짐 개선 화장료 조성물은;Skin sagging cosmetic composition of the present invention for achieving the above object;

통상의 화장료 조성물에 디카르복시 카노신 하이드로클로라이드(Decarboxy Carnosine 2HCl; Carcinine) 0.1 ~ 2 중량%, 지실에서 추출한 에센셜 오일 0.001 ~ 0.5 중량% 및 소맥 단백질과 폴리비닐피롤리돈(polyvinylpyrrolidone, PVP)의 중합체 0.01 ~ 5.0중량%를 함유하는 것을 특징으로 한다.0.1 to 2% by weight of Decarboxy Carnosine 2HCl (Carcinine), 0.001 to 0.5% by weight of essential oil extracted from the fruit room, and a polymer of wheat protein and polyvinylpyrrolidone (PVP) in a conventional cosmetic composition It is characterized by containing 0.01 to 5.0% by weight.

상기 본 발명의 구성에 따른 조성물의 구성요소인 디카르복시 카노신 하이드로클로라이드(Decarboxy Carnosine 2HCl; Carcinine)는 0.1 ~ 2 중량% 함유되며, 상기 디카르복시 카노신 하이드로클로라이드는 카노신을 디카르복실레이션시켜 안정화한 것으로 항산화 효과, 염증성 질환 치료, 광보호 효과 등 다양한 효능을 가지고 있는 것으로 알려져 있는 물질이다. 본 발명에서는 상기 디카르복시 카노신 하이드로클로라이드가 콜라겐 합성 증가효과를 보임으로써 피부탄력을 증대키는데 적용할 수 있는 유용한 작용효과를 갖는다.Dicarboxy carnosine 2HCl (Carcinine) is a component of the composition according to the composition of the present invention is contained 0.1 to 2% by weight, the dicarboxy carnosine hydrochloride is stabilized by decarboxylation of carnosine It is a substance known to have various effects such as antioxidant effect, inflammatory disease treatment, photoprotective effect. In the present invention, the dicarboxy carnosine hydrochloride has a useful effect that can be applied to increase skin elasticity by showing an collagen synthesis increase effect.

상기 본 발명의 구성에 따른 조성물의 다른 구성요소인 지실에서 추출한 에센셜 오일은 0.001 ~ 0.5 중량% 함유된다. 탱자나무(Poncirus trifoliata Rafin.) 열매를 덜 익었을 때 2~3조각으로 잘라 말린 것을 '지실'이라고 하며 한방에서는 습진 치료 및 기의 순환을 돕는데 사용한다. 본 발명에서는 상기 물질이 엘라스틴 분해를 억제하여 궁극적으로 피부탄력을 향상시키는데 적용할 수 있는 유용한 작용효과를 갖는다.The essential oil extracted from the basement which is another component of the composition according to the composition of the present invention contains 0.001 to 0.5% by weight. Poncirus trifoliata Rafin. When the fruit is less cooked, it is cut into two or three pieces and dried. It is called 'pile' and it is used to treat eczema and the circulation of chi. In the present invention, the substance has a useful effect that can be applied to inhibit elastin degradation and ultimately improve skin elasticity.

상기 본 발명의 구성에 따른 조성물의 다른 구성요소인 소맥 단백질과 폴리비닐피롤리돈(polyvinylpyrrolidone, PVP)의 중합체는 0.01 ~ 5.0중량% 함유된다. 상기 중합체는 분자량이 약 40,000 정도로 그 구성성분인 소맥 단백질과 폴리비닐피롤리돈은 모두 필름형성제로 사용되어진다. 본 발명에서는 상기 중합체가 피부의 즉각적인 신장성을 줄여주며 인지할만한 당김효과를 주는데 적용할 수 있는 유용한 작용효과를 갖는다.Other components of the composition according to the composition of the present invention, the polymer of wheat protein and polyvinylpyrrolidone (polyvinylpyrrolidone, PVP) is contained 0.01 to 5.0% by weight. The polymer has a molecular weight of about 40,000 and its constituent wheat protein and polyvinylpyrrolidone are both used as film forming agents. In the present invention, the polymer has a useful effect that can be applied to reduce the immediate extensibility of the skin and give a noticeable pulling effect.

상기와 같이 구성되는 본 발명은 디카르복시 카노신 하이드로클로라이드, 지실의 에센셜 오일 및 가수분해 된 소맥 단백질과 폴리비닐피롤리돈 중합체를 일정 비율로 포함함으로 진피층 내의 탄력성분을 증진시켜 피부탄력을 개선하고 피부표면에 단백질 막을 형성하여 처진 피부를 개선하는 효과를 가지는 화장료 조성물을 제공하며, 이하에서 상기 본 발명의 구성성분을 통칭하여 피부처짐개선성분(Anti-lifting effector)으로 명명한다.The present invention constituted as described above includes dicarboxy carnosine hydrochloride, essential oil of fibril, hydrolyzed wheat protein and polyvinylpyrrolidone polymer in a proportion to improve elasticity in the dermal layer and improve skin elasticity. It provides a cosmetic composition having the effect of improving the sagging skin by forming a protein film on the skin surface, hereinafter referred to as the component of the present invention is called as an anti-lifting effect (Anti-lifting effector).

본 발명의 다른 구성에 따르면, 상기의 피부처짐개선성분은 제형별 화장료에 적용한다. 더욱 자세하게는, 디카르복시 카노신 하이드로클로라이드(Decarboxy Carnosine 2HCl; Carcinine)를 0.1 ~ 2 중량% 및 지실에서 추출한 에센셜 오일을 0.001 ~ 0.5 중량% 그리고 소맥 단백질과 폴리비닐피롤리돈(polyvinylpyrrolidone, PVP)의 중합체를 0.01 ~ 5.0중량%로 함유하는 범위 내에서 피부처짐 개선 효과를 가지는 여러 형태의 화장료로 제조될 수 있다.According to another configuration of the present invention, the skin sagging improvement component is applied to the cosmetic for each formulation. More specifically, 0.1% to 2% by weight of decarboxy Carnosine 2HCl (Carcinine) and 0.001% to 0.5% by weight of essential oil extracted from the fruit room and wheat protein and polyvinylpyrrolidone (PVP) It can be prepared in various forms of cosmetics having a skin sagging effect within the range containing 0.01 to 5.0% by weight of the polymer.

이하, 본 발명을 실시예 및 비교예, 실험예를 통하여 보다 자세하게 설명한다. 그러나 이들 실시예 및 비교예, 실험예는 본 발명에 대한 이해를 돕기위한 것일 뿐 본 발명의 범위가 하기 실시예 및 실험예에 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail through Examples, Comparative Examples, and Experimental Examples. However, these Examples, Comparative Examples, and Experimental Examples are provided only to assist in understanding the present invention, and the scope of the present invention is not limited to the following Examples and Experimental Examples.

실시예1-2, 비교예1-2Example 1-2, Comparative Example 1-2

상기 본 발명의 구성에 따라 다음 표1과 같은 조성의 화장료를 제조하였다.According to the configuration of the present invention to prepare a cosmetic composition of the following Table 1.

성 분ingredient 함 량 (중량%)Content (% by weight) 실시예 1Example 1 실시예 2Example 2 비교예 1Comparative Example 1 비교예 2Comparative Example 2 카보머Carbomer 0.50.5 -- -- -- 가수분해 된 소맥단백질(250,00 Mw)Hydrolyzed Wheat Protein (250,00 Mw) -- -- 55 -- 가수분해 된 소맥단백질(500,000 Mw)Hydrolyzed Wheat Protein (500,000 Mw) -- -- -- 1One 가수분해 된 소맥 단백질과 폴리비닐피롤리돈 중합체Hydrolyzed Wheat Protein and Polyvinylpyrrolidone Polymers 1One 1One -- -- 정제수Purified water 적량Quantity 적량Quantity 적량Quantity 적량Quantity 트리에탄올아민Triethanolamine 적량 (pH 6.5 ~ 7.0)Correct amount (pH 6.5 ~ 7.0) -- -- -- 합계Sum 100100 100100 100100 100100

실시예3, 비교예3-6Example 3, Comparative Example 3-6

다음 표2와 같은 조성의 화장료를 제조하였다.Next, a cosmetic composition was prepared as shown in Table 2.

성 분ingredient 실시예 3Example 3 비교예 3Comparative Example 3 비교예 4Comparative Example 4 비교예 5Comparative Example 5 비교예 6Comparative Example 6 글리세린glycerin 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 1,3 - 부틸렌글리콜1,3-butylene glycol 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 세스퀴올레인산소르비탄Sesquioleate sorbitan 0.40.4 0.40.4 0.40.4 0.40.4 0.40.4 폴리라우린산폴리옥시에틸렌소르비탄Polylauric acid polyoxyethylene sorbitan 1.01.0 1.01.0 1.01.0 1.01.0 1.01.0 파라옥시안식향산메칠Paraoxybenzoic Acid Methyl 0.20.2 0.20.2 0.20.2 0.20.2 0.20.2 에탄올ethanol 2.02.0 2.02.0 2.02.0 2.02.0 2.02.0 바세린Vaseline 5.05.0 5.05.0 5.05.0 5.05.0 5.05.0 세탄올Cetanol 0.20.2 0.20.2 0.20.2 0.20.2 0.20.2 디카르복시 카노신 하이드로클로라이드Dicarboxy Carnosine Hydrochloride 0.10.1 -- 0.10.1 0.10.1 지실 에센셜 오일Basement Essential Oil 0.0010.001 -- 0.0010.001 -- 0.0010.001 가수분해 된 소맥 단백질과 폴리비닐피롤리돈 중합체Hydrolyzed Wheat Protein and Polyvinylpyrrolidone Polymers 1One -- 1 One 1One -- 정제수Purified water 잔부Balance 잔부Balance 잔부Balance 잔부Balance 잔부Balance

실험예 1Experimental Example 1

콜라겐 섬유 생합성 효과(카르시닌의 효과)Collagen Fiber Biosynthesis Effect (Effect of Carcinin)

섬유아세포(fibroblast W138)를 48well 플레이트에 5×104 cell/well 이 되도록 하여 24시간동안 배양하였다. 상층액 제거 후 무혈청 배양배지에 농도별로 디카르복시 카노신 하이드로클로라이드를 희석하여 처리하였다. 24시간 후 각 웰의 상층액을 수집하여 프로콜라겐 타입 IC-펩타이드(Procollagen type IC-peptide; PICP)의 양을 콜라겐 섬유 생합성 측정용 키트(Procollagen Type IC-peptide EIA kit: Takara MK101)를 사용하여 450nm에서 흡광도를 측정하였다. 양성 대조군으로는 TGF-β를 사용하였고 10 ng/ml로 처리하였다.Fibroblasts (fibroblast W138) were incubated for 24 hours with 5 × 10 4 cells / well in a 48 well plate. After removal of the supernatant, dicarboxylic carnosine hydrochloride was treated by diluting the serum-free culture medium by concentration. After 24 hours, the supernatant of each well was collected and the amount of procollagen type IC-peptide (PICP) was measured using a collagen fiber biosynthesis kit (Procollagen Type IC-peptide EIA kit: Takara MK101). Absorbance was measured at 450 nm. TGF-β was used as a positive control and treated at 10 ng / ml.

디카르복시 카노신 하이드로클로라이드(ug/ml)Dicarboxy carnosine hydrochloride (ug / ml) O.D.O.D. 콜라겐(ng/mL)Collagen (ng / mL) % of control% of control 00 1.4581.458 52.352.3 00 55 2.2122.212 79.7**79.7 ** 52.752.7 1010 2.3572.357 84.6**84.6 ** 61.761.7 5050 2.6872.687 116.6**116.6 ** 122.9122.9

상기 표 3에서 보는바와 같이, 디카르복시 카노신 하이드로클로라이드는 농도의존적으로 콜라겐합성을 증가시켰다. 양성대조군으로 사용된 TGF-β의 50 ug/ml에서의 콜라겐 합성량이 118.9 ng/ml 이었다. 이와 비교해 볼때 디카르복시 카노신 하이드로클로라이드는 50 ug/ml에서 약 98%의 유의한 콜라겐 합성효과가 있음을 알 수 있었다.As shown in Table 3, dicarboxy carnosine hydrochloride increased collagen synthesis in a concentration-dependent manner. The amount of collagen synthesis at 50 ug / ml of TGF-β used as a positive control was 118.9 ng / ml. In comparison, dicarboxy carnosine hydrochloride was found to have a significant collagen synthesis effect of about 98% at 50 ug / ml.

실험예 2Experimental Example 2

엘라스틴 분해 억제 효과(지실 에센스의 효과)Elastin Degradation Inhibitory Effect (Effect of Lost Essence)

96 웰 마이크로 플레이트(96-well microplate)에 완충액 100 ul씩 넣고 지실 에센셜 오일을 각 농도별로 50 ul씩 넣는다. 그 후 기질인 니트로아닐리드(Succinyl-Ala-Ala-Pro-Phe-p-nitroanilide, Calbiochem)를 25ul 넣은 후 분해효소 엘라스타제(Elastase, Sigma)를 각 웰에 25 ul씩 넣음으로써 반응을 일으킨다. 반응 시작 20분 후 410nm에서 흡광도를 측정하여 지실에센셜 오일의 엘라스틴 분해 억제효과를 대조군에 대한 비율로 나타낸다. 그 결과를 표 4에 나타내었다.Into a 96-well microplate, add 100 ul of buffer and 50 ul of fissure essential oil for each concentration. Subsequently, 25ul of nitroanilide (Succinyl-Ala-Ala-Pro-Phe-p-nitroanilide, Calbiochem), which is a substrate, is added thereto, and a reaction is caused by adding 25 ul of the enzyme delastase (Elastase, Sigma) to each well. 20 minutes after the start of the reaction, the absorbance at 410 nm was measured to show the effect of inhibiting the elastin degradation of the silyl essential oil as a ratio to the control group. The results are shown in Table 4.

농 도(ppm)Concentration (ppm) 엘라스틴 분해 억제효과(%)Elastin inhibitory effect (%) 1010 1515 5050 2525 100100 5050

실험예 3Experimental Example 3

피부의 조임 효과 (소맥 단백질과 폴리비닐피롤리돈 중합체의 효과)Tightening effect of skin (effect of wheat protein and polyvinylpyrrolidone polymer)

팔의 상박 안쪽 세군데를 측정 부위로 하고 상기 실시예 2와 비교예 1, 2에 따라 제조된 화장료를 바른 두시간 후 DTM(Dermal Torque Meter, Dia-Stron Limited, Hampshire, England)기기로 15초동안 10 mNm(milli Newton meters)을 적용한다. 그 후 DTM 기기를 떼어내고 15초동안 피부가 완화되는 것을 관찰한다. 이때 측정되는 즉각적인 피부 신장성(Ue; Immediate extensibility)은 고분자 단백질에 의해 형성되는 피부의 조임성 측정에 사용된다. 피시험자 5 내지 6명에 대해 5일동안 실시하여 표 5와 같은 결과를 나타내었고 Ue값의 변화는 도 1에서 보는바와 같다.After two hours of applying the cosmetics prepared according to Examples 2 and Comparative Examples 1 and 2, the upper three upper arms of the upper arm, 10 minutes for 15 seconds with a DTM (Dermal Torque Meter, Dia-Stron Limited, Hampshire, England) Milli Newton meters (mNm) apply. Then remove the DTM device and observe the skin relax for 15 seconds. Immediate extensibility (Ue) measured at this time is used to measure the tightness of the skin formed by the polymer protein. 5 to 6 subjects were carried out for 5 days and the results are shown in Table 5. The change of Ue value is as shown in FIG.

5일동안 Ue의 평균변화율(%)% Change in Ue over 5 days 비교예 1Comparative Example 1 - 3.8 ±0.005-3.8 ± 0.005 비교예 2Comparative Example 2 - 6.4 ±0.05-6.4 ± 0.05 실시예 2Example 2 - 8.2 ±0.0058.2 ± 0.005

상기 표 5에서 보는 바와같이 실험기간동안 Ue값이 유의하게 줄어들었음을 알 수 있다. 실시예 2는 - 8.2로 비교예 1, 2에 비해 탁월한 감소효과를 보였다.  As shown in Table 5, it can be seen that the Ue value was significantly decreased during the experiment. Example 2 showed an excellent reduction effect compared to Comparative Examples 1 and 2 at-8.2.

이를 근거로 실시예 1의 조성을 사용하여 겔제형 내에서의 소맥 단백질 중합체의 효과를 알아 본 결과, 5일간의 평균 Ue 변화율은 -3.0 %로 그 측정값을 도 2에 나타내었다. Based on this, the effect of the wheat protein polymer in the gel formulation was determined using the composition of Example 1, and the average Ue change rate over 5 days was -3.0%, and the measured value is shown in FIG. 2.

실험예 4 Experimental Example 4

수분 보유능 측정 Moisture Retention Measurement

상기 실시예3 및 비교예3-6에 따라 제조된 통상의 에센스 제형을 이용하여 본 실험을 실시하였다.This experiment was carried out using conventional essence formulations prepared according to Example 3 and Comparative Example 3-6.

피시험자 성인 남녀 20명을 30분 이상 항온항습실에서 휴식을 취하게 한 후, 팔하박부 안쪽에 4 ×4㎠의 구획을 설정한 후 제품을 2㎍/㎤의 두께로 도포하고 시간의 경과에 따라 피부수분 함유량을 코니오미터(Corneometer CM 820, Courage + Khazaka electronic Gmbh사, Germany)를 이용하여 측정하였다. 그 결과를 표 6에 나타내었다.Allow 20 adult men and women to rest in a constant temperature and humidity room for at least 30 minutes, set a 4 × 4 cm 2 compartment inside the lower arm, and apply the product at a thickness of 2 µg / cm 3. Skin moisture content was measured using a coronometer (Corneometer CM 820, Courage + Khazaka electronic Gmbh, Germany). The results are shown in Table 6.

도포전측정평균값Average value measured before application 도포후 측정평균값Average value measured after application 1시간1 hours 2시간2 hours 3시간3 hours 4시간4 hours 실시예 3Example 3 6666 8585 8181 7979 7171 비교예 3Comparative Example 3 6464 8787 8282 7171 6262 비교예 4Comparative Example 4 6262 8080 7878 7373 6565 비교예 5Comparative Example 5 6666 8686 8383 7878 6969 비교예 6Comparative Example 6 6565 8585 7979 7272 6666

상기 표 6에서 보는바와 같이, 조성물을 함유한 실시예 3의 경우가 비교예 3, 4, 5, 6에 비하여 탁월한 수분보유능을 나타내었다.As shown in Table 6, the case of Example 3 containing the composition showed an excellent moisture retention capacity compared to Comparative Examples 3, 4, 5, 6.

실험예 5Experimental Example 5

사용성 테스트Usability Test

실시예 3 및 비교예 3에 대하여 20~35세의 여성패널 30명을 대상으로 3주동안 사용후 설문에 의한 평가를 실시하였다. 제품은 매일 아침과 저녁에 2회에 걸쳐 사용하였고 5 포인트 스케일로 평가하여 그 결과를 표 7에 나타내었다.In Example 3 and Comparative Example 3, 30 female panelists 20 to 35 years old were evaluated by a post-use questionnaire for 3 weeks. The product was used twice daily in the morning and evening and evaluated on a 5-point scale and the results are shown in Table 7.

시험항목Test Items 실시예 3Example 3 비교예 3Comparative Example 3 조임성 Tightening 55 1212 66 44 1010 55 33 44 1414 22 33 33 1One 1One 22 평균Average 3.963.96 3.33.3 보습성 Moisturizing 55 55 22 44 1212 1111 33 1010 1010 22 33 66 1One -- 1One 평균Average 3.633.63 3.233.23 자극성 pepper 55 -- -- 44 1One 22 33 33 1One 22 66 88 1One 2222 1919 평균Average 1.561.56 1.531.53

* 5 포인트 스케일 : * 5 point scale:

5 : 매우 좋다(강자극) 4 : 좋다(자극) 3 : 보통(약자극) 5: Very good (strong stimulus) 4: Good (stimulus) 3: Normal (weak stimulus)

2 : 나쁨(보통) 1 : 매우 나쁨(자극없음)2: bad (normal) 1: very bad (no irritation)

상기 표 7에서 보는바와 같이, 조성물을 포함한 실시예 3의 경우 포함하지 않은 비교예 3에 비해 조임성 및 보습성에 있어서 더 나은 효과가 있었고 자극성은 두 제품 모두 보통 이하로 나타났다.As shown in Table 7, in the case of Example 3 including the composition had a better effect on tightening and moisturizing compared to Comparative Example 3 not included and the irritation was less than normal for both products.

상기 본 발명의 구성에 따른 피부처짐 개선 화장료 조성물은 콜라겐 합성효과가 있는 디카르복시 카노신 하이드로클로라이드와 엘라스틴 분해억제 효과가 있는 지실의 에센셜 오일 및 수분보유 효과와 피부조임 효과가 있는 소맥 단백질과 폴리비닐피롤리돈(polyvinylpyrrolidone, PVP)의 중합체를 각종 화장료에 일정성분으로 함유하여 진피의 피부탄력을 향상시키고 처진피부를 개선하는 유용한 작용이 있는 화장료 조성물을 제공한다.Skin sag improvement cosmetic composition according to the composition of the present invention is essential oil and moisture retention effect and skin tightening effect of dicarboxy carnosine hydrochloride and elastin degradation inhibitory effect collagen synthesis and polyvinyl It contains a polymer of pyrrolidone (polyvinylpyrrolidone, PVP) in a variety of cosmetics to provide a cosmetic composition having a useful action to improve the skin elasticity of the dermis and improve sagging skin.

도 1은 본 발명의 구성성분인 시료를 도포 한 후 즉각적인 피부 신장성 값의 변화를 나타낸 그래프이고,1 is a graph showing a change in the skin extensibility immediately after applying a sample of the present invention,

도 2는 실시예 1의 조성을 사용한 겔제형 내에서의 소맥 단백질 중합체의 효과를 알아 본 것으로 5일간의 즉각적인 피부 신장성 변화율을 평균값으로 나타낸 그래프이다. Figure 2 is a graph showing the effect of the wheat protein polymer in the gel formulation using the composition of Example 1 as an average value of the change rate of the immediate skin elongation for 5 days.

Claims (2)

통상의 화장료 조성물에 디카르복시 카노신 하이드로클로라이드(Decarboxy Carnosine 2HCl; Carcinine) 0.1 ~ 2 중량%, 지실에서 추출한 에센셜 오일 0.001 ~ 0.5 중량% 그리고 소맥 단백질과 폴리비닐피롤리돈(polyvinylpyrrolidone, PVP)의 중합체 0.01 ~ 5.0중량%를 함유하는 것을 특징으로 하는 피부처짐 개선 화장료 조성물.0.1 to 2% by weight of Decarboxy Carnosine 2HCl (Carcinine), 0.001 to 0.5% by weight of essential oil extracted from fruit room, and polymer of wheat protein and polyvinylpyrrolidone (PVP) in a conventional cosmetic composition A skin sagging cosmetic composition comprising 0.01 to 5.0% by weight. 제 1항에 따른 화장료 조성물의 제형은 유연화장수, 영양화장수, 영양크림, 마사지크림, 에센스, 겔타입의 화장료 제형에서 선택된 하나임을 특징으로 하는 피부처짐 개선 화장료 조성물.The cosmetic composition of claim 1, wherein the formulation of the cosmetic composition according to claim 1 is selected from a flexible cosmetics, nourishing cosmetics, nutrition cream, massage cream, essence, gel type cosmetic formulation.
KR10-2003-0050958A 2003-07-24 2003-07-24 Cosmetic composition having anti-lifting effector KR100520645B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR10-2003-0050958A KR100520645B1 (en) 2003-07-24 2003-07-24 Cosmetic composition having anti-lifting effector

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR10-2003-0050958A KR100520645B1 (en) 2003-07-24 2003-07-24 Cosmetic composition having anti-lifting effector

Publications (2)

Publication Number Publication Date
KR20050011895A KR20050011895A (en) 2005-01-31
KR100520645B1 true KR100520645B1 (en) 2005-10-13

Family

ID=37223820

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2003-0050958A KR100520645B1 (en) 2003-07-24 2003-07-24 Cosmetic composition having anti-lifting effector

Country Status (1)

Country Link
KR (1) KR100520645B1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100920898B1 (en) * 2007-10-30 2009-10-12 주식회사 코리아나화장품 Pore astringent cosmetic composition containing Poncirus trifoliate extract and hydrogenated phosphatidylcholine
KR100946584B1 (en) * 2007-11-29 2010-03-09 주식회사 코리아나화장품 Cosmetic Composition Comprising Poncirus trifoliata fruit extract and Nymphaea caerulea extract
KR101280306B1 (en) * 2011-06-28 2013-07-01 에치엔지화장품주식회사 A cosmetic composition for anti-aging containing an extract of poncirus trifoliata by bioconversion

Also Published As

Publication number Publication date
KR20050011895A (en) 2005-01-31

Similar Documents

Publication Publication Date Title
KR101345735B1 (en) Cosmetic composition with the extract of ginseng berry fermented with pleurotus ferulae
KR102139472B1 (en) Anti-aging composition comprising functional peptides and fermented products
JP3556595B2 (en) Cosmetic composition for skin protection containing retinol and epidermal growth factor
KR102373899B1 (en) Multifunctional cosmetic composition containing complex natural extracts effective for skin wrinkle improvement, whitening, cell regeneration, and wound healing as an active ingredient
KR100994987B1 (en) Cosmetic composition with the calming effect for skins
JP2000136124A (en) Skin lotion
KR20230130489A (en) Cosmetic materials for skin-whitening and anti-wrinkle, Cosmetics containing the same, and Manufacturing method thereof
KR101437997B1 (en) Fermented caviar extract and its cosmetic usage
KR100520645B1 (en) Cosmetic composition having anti-lifting effector
KR101753874B1 (en) A cosmetic composition comprising a decapeptide as an active ingredient
JPH11100320A (en) Preparation for external use for skin
KR102129430B1 (en) Cosmetic composition comprising functional peptides and fermented products
KR102382002B1 (en) A multifunctional cosmetic composition for elasticity, anti-wrinkle, inhibiting tyrosinase comprising peptide complex and natural ingredients
KR102281606B1 (en) A multifunctional cosmetic composition for elasticity, anti-wrinkle, inhibiting tyrosinase comprising peptide complex
KR101997231B1 (en) Cosmetic composition containing enzyme-treated honey extract
KR102010345B1 (en) Cosmetic materials composition having inhibitor of skin photo-aging and regeneration of skin wound-cell, Cosmetic materials using the same and Manufacturing method thereof
JPH11158054A (en) Skin lotion
KR100424728B1 (en) Whitening and wrinkle improvement cosmetics composition containing Areca catechu extract and Arbutin
KR100702330B1 (en) Cosmetic Composition for Inhibition of Skin Aging Comprising the Extract of Areca catechu and Synthetic Palmitoylpentapeptide as an Active Ingredient
KR100424726B1 (en) Skin care cosmetic composition containing stabilized vitamin C and phytosphingosine
CN111000765A (en) Whitening composition containing ginseng enzyme and application thereof
KR102432887B1 (en) Skin health improvement set including skin cosmetics and edible film and skin care method using the same
KR102532713B1 (en) Novel Saccharomyces cerevisiae strain and use thereof
KR101061612B1 (en) Cosmetic composition for promoting exfoliation
KR102432888B1 (en) Edible film and skin care method using the same

Legal Events

Date Code Title Description
A201 Request for examination
A302 Request for accelerated examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20120913

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20130904

Year of fee payment: 9

FPAY Annual fee payment

Payment date: 20140912

Year of fee payment: 10

FPAY Annual fee payment

Payment date: 20150916

Year of fee payment: 11

FPAY Annual fee payment

Payment date: 20160907

Year of fee payment: 12

FPAY Annual fee payment

Payment date: 20170908

Year of fee payment: 13

FPAY Annual fee payment

Payment date: 20180912

Year of fee payment: 14

FPAY Annual fee payment

Payment date: 20190909

Year of fee payment: 15